| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.07T | 12.63T | 12.69T | 10.60T | 8.42T | 7.86T |
| Gross Profit | 1.47T | 1.62T | 2.00T | 1.65T | 1.30T | 995.61B |
| EBITDA | 634.56B | 767.84B | 1.25T | 1.07T | 937.33B | 559.11B |
| Net Income | -926.27B | -670.90B | 426.65B | 221.90B | 215.53B | -448.70B |
Balance Sheet | ||||||
| Total Assets | 19.69T | 19.02T | 19.86T | 17.60T | 16.37T | 16.45T |
| Cash, Cash Equivalents and Short-Term Investments | 2.21T | 2.20T | 2.13T | 2.01T | 1.79T | 2.03T |
| Total Debt | 5.68T | 4.48T | 5.41T | 4.21T | 4.17T | 4.34T |
| Total Liabilities | 14.36T | 13.58T | 13.38T | 11.98T | 11.34T | 12.11T |
| Stockholders Equity | 4.90T | 4.96T | 5.98T | 5.13T | 4.58T | 3.94T |
Cash Flow | ||||||
| Free Cash Flow | -849.09B | -1.16T | -666.88B | 87.55B | -276.70B | 140.48B |
| Operating Cash Flow | 839.49B | 753.69B | 960.90B | 1.22T | 847.19B | 1.32T |
| Investing Cash Flow | -967.07B | -971.23B | -812.66B | -445.39B | -141.52B | -366.24B |
| Financing Cash Flow | 187.70B | 263.25B | -131.55B | -672.26B | -1.10T | -642.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥3.56T | 9.91 | 13.26% | 1.85% | 2.99% | 9.99% | |
68 Neutral | ¥6.34T | 13.95 | 4.59% | 0.78% | 2.91% | -11.26% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥1.79T | -82.83 | 9.73% | 3.61% | 1.04% | -31.52% | |
56 Neutral | ¥4.88T | 9.73 | 4.09% | 4.41% | -0.43% | -26.68% | |
55 Neutral | ¥655.69B | 6.29 | 1.72% | 4.52% | -0.83% | -75.20% | |
47 Neutral | ¥1.21T | -12.05 | -16.69% | ― | -3.01% | -755.71% |